Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults DOI Creative Commons
Andrew L. Young, Grant A. Challen, Brenda M. Birmann

et al.

Nature Communications, Journal Year: 2016, Volume and Issue: 7(1)

Published: Aug. 22, 2016

Abstract Clonal haematopoiesis is thought to be a rare condition that increases in frequency with age and predisposes individuals haematological malignancy. Recent studies, utilizing next-generation sequencing (NGS), observed haematopoietic clones 10% of 70-year olds rarely younger individuals. However, these studies could only detect common clones—>0.02 variant allele fraction (VAF)—due the error rate NGS. To identify characterize clonal mutations below this threshold, here we develop methods for targeted error-corrected sequencing, which enable accurate detection as 0.0003 VAF. We apply study serially banked peripheral blood samples from healthy 50–60-year-old participants Nurses’ Health Study. observe haematopoiesis, frequently harbouring DNMT3A TET2 , 95% studied. These are often stable longitudinally present multiple compartments, suggesting long-lived stem progenitor cell origin.

Language: Английский

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel DOI Open Access
Hartmut Döhner, Elihu H. Estey,

David Grimwade

et al.

Blood, Journal Year: 2016, Volume and Issue: 129(4), P. 424 - 447

Published: Nov. 29, 2016

Language: Английский

Citations

5165

Genomic Classification and Prognosis in Acute Myeloid Leukemia DOI Open Access

Elli Papaemmanuil,

Moritz Gerstung, Lars Bullinger

et al.

New England Journal of Medicine, Journal Year: 2016, Volume and Issue: 374(23), P. 2209 - 2221

Published: June 8, 2016

Recent studies have provided a detailed census of genes that are mutated in acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity defines the pathophysiology AML and informs clinical practice.

Language: Английский

Citations

3561

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease DOI Open Access
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J. Silver

et al.

New England Journal of Medicine, Journal Year: 2017, Volume and Issue: 377(2), P. 111 - 121

Published: June 21, 2017

Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence an expanded somatic blood-cell clone in persons without other hematologic abnormalities, common among older and associated with increased risk cancer. We previously found preliminary evidence for association between CHIP atherosclerotic cardiovascular disease, but nature this was unclear.

Language: Английский

Citations

2167

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes DOI Open Access
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal

et al.

Blood, Journal Year: 2015, Volume and Issue: 126(1), P. 9 - 16

Published: May 1, 2015

Language: Английский

Citations

1727

Putting p53 in Context DOI Creative Commons
Edward R. Kastenhuber,

Scott W. Lowe

Cell, Journal Year: 2017, Volume and Issue: 170(6), P. 1062 - 1078

Published: Sept. 1, 2017

Language: Английский

Citations

1641

High burden and pervasive positive selection of somatic mutations in normal human skin DOI
Iñigo Martincorena, Amit Roshan, Moritz Gerstung

et al.

Science, Journal Year: 2015, Volume and Issue: 348(6237), P. 880 - 886

Published: May 22, 2015

How somatic mutations accumulate in normal cells is central to understanding cancer development but poorly understood. We performed ultradeep sequencing of 74 genes small (0.8 4.7 square millimeters) biopsies skin. Across 234 sun-exposed eyelid epidermis from four individuals, the burden averaged two six per megabase cell, similar that seen many cancers, and exhibited characteristic signatures exposure ultraviolet light. Remarkably, multiple are under strong positive selection even physiologically skin, including most key drivers cutaneous squamous cell carcinomas. Positively selected were found 18 32% skin at a density ~140 driver centimeter. observed variability landscape among individuals sizes clonal expansions across genes. Thus, aged patchwork thousands evolving clones with over quarter carrying cancer-causing while maintaining physiological functions epidermis.

Language: Английский

Citations

1638

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology DOI Open Access
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian

et al.

Journal of the National Comprehensive Cancer Network, Journal Year: 2018, Volume and Issue: 16(3), P. 310 - 320

Published: March 1, 2018

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group neoplastic lesions ducts. The goal for management DCIS is to prevent development invasive cancer. This manuscript focuses on NCCN Guidelines Panel recommendations workup, primary treatment, risk reduction strategies, and surveillance specific DCIS.

Language: Английский

Citations

1598

Universal Patterns of Selection in Cancer and Somatic Tissues DOI Creative Commons
Iñigo Martincorena, Keiran Raine, Moritz Gerstung

et al.

Cell, Journal Year: 2017, Volume and Issue: 171(5), P. 1029 - 1041.e21

Published: Oct. 19, 2017

Cancer develops as a result of somatic mutation and clonal selection, but quantitative measures selection in cancer evolution are lacking. We adapted methods from molecular applied them to 7,664 tumors across 29 types. Unlike species evolution, positive outweighs negative during development. On average, <1 coding base substitution/tumor is lost through with purifying almost absent outside homozygous loss essential genes. This allows exome-wide enumeration all driver mutations, including known carry ∼4 substitutions under ranging <1/tumor thyroid testicular cancers >10/tumor endometrial colorectal cancers. Half occur yet-to-be-discovered With increasing burden, numbers mutations increase, not linearly. systematically catalog genes show that vary extensively what proportion drivers versus passengers.

Language: Английский

Citations

1323

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice DOI Open Access
José J. Fuster, Susan MacLauchlan, María A. Zuriaga

et al.

Science, Journal Year: 2017, Volume and Issue: 355(6327), P. 842 - 847

Published: Jan. 20, 2017

Human aging is associated with an increased frequency of somatic mutations in hematopoietic cells. Several these recurrent mutations, including those the gene encoding epigenetic modifier enzyme TET2, promote expansion mutant blood This clonal hematopoiesis correlates risk atherosclerotic cardiovascular disease. We studied effects Tet2-mutant cells atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr-/-) mice. found that partial bone marrow reconstitution TET2-deficient was sufficient for their and led to a marked increase plaque size. macrophages exhibited NLRP3 inflammasome-mediated interleukin-1β secretion. An inhibitor showed greater atheroprotective activity chimeric mice reconstituted than nonchimeric These results support hypothesis TET2 play causal role atherosclerosis.

Language: Английский

Citations

1226

Current and future perspectives of liquid biopsies in genomics-driven oncology DOI
Ellen Heitzer, Imran S. Haque,

Charles E. S. Roberts

et al.

Nature Reviews Genetics, Journal Year: 2018, Volume and Issue: 20(2), P. 71 - 88

Published: Nov. 8, 2018

Language: Английский

Citations

1173